COVID-19 update: Covid-19-associated coagulopathy

RC Becker - Journal of thrombosis and thrombolysis, 2020 - Springer
The Covid-19 pandemic has introduced an array of organspecific and systemic phenotypes-
some previously observed in viral infections, including severe acute respiratory syndrome …

[HTML][HTML] Pharmacological agents targeting thromboinflammation in COVID-19: review and implications for future research

B Bikdeli, MV Madhavan, A Gupta… - Thrombosis and …, 2020 - thieme-connect.com
Coronavirus disease 2019 (COVID-19), currently a worldwide pandemic, is a viral illness
caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The …

Prevention, diagnosis, and treatment of VTE in patients with coronavirus disease 2019: CHEST guideline and expert panel report

LK Moores, T Tritschler, S Brosnahan, M Carrier… - Chest, 2020 - Elsevier
Background Emerging evidence shows that severe coronavirus disease 2019 (COVID-19)
can be complicated by a significant coagulopathy, that likely manifests in the form of both …

[HTML][HTML] Pulmonary embolism in patients with COVID-19 pneumonia

F Bompard, H Monnier, I Saab… - European …, 2020 - publications.ersnet.org
Acute respiratory distress syndrome development in patients with coronavirus disease 2019
(COVID-19) pneumonia is associated with a high mortality rate and is the main cause of …

NICE guideline on long covid

M Sivan, S Taylor - Bmj, 2020 - bmj.com
NICE guideline on long covid Page 1 NICE guideline on long covid Research must be done
urgently to fill the many gaps in this new “living guideline” Manoj Sivan, 1, 2 Sharon Taylor3, 4 …

[HTML][HTML] Hypofibrinolytic state and high thrombin generation may play a major role in SARS‐COV2 associated thrombosis

C Nougier, R Benoit, M Simon… - Journal of Thrombosis …, 2020 - Elsevier
Abstract Background Thirty percent of Covid‐19 patients admitted to intensive care units
present with thrombotic complications despite thromboprophylaxis. Bed rest, obesity …

Pulmonary embolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: a narrative review

Y Sakr, M Giovini, M Leone, G Pizzilli, A Kortgen… - Annals of intensive …, 2020 - Springer
Background Preliminary reports have described significant procoagulant events in patients
with coronavirus disease-2019 (COVID-19), including life-threatening pulmonary embolism …

The East Asian paradox: an updated position statement on the challenges to the current antithrombotic strategy in patients with cardiovascular disease

HK Kim, US Tantry, SC Smith Jr… - Thrombosis and …, 2021 - thieme-connect.com
East Asian patients have reduced anti-ischemic benefits and increased bleeding risk during
antithrombotic therapies compared with Caucasian patients. As potent P2Y 12 receptor …

Cerebral venous sinus thrombosis as a presentation of COVID-19

C Hughes, T Nichols, M Pike, C Subbe… - European journal of …, 2020 - pmc.ncbi.nlm.nih.gov
Coronavirus disease 19 (COVID-19) is caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2). We describe the case of a 59-year-old man who presented …

Chronic kidney disease and acute kidney injury in the COVID-19 Spanish outbreak

J Portolés, M Marques, P López-Sánchez… - Nephrology Dialysis …, 2020 - academic.oup.com
Background Novel coronavirus disease 2019 (COVID-19) emerged in Wuhan and rapidly
spread, affecting> 10 million cases worldwide. Caused by severe acute respiratory …